Between 20% and 30% of the chronic patients develop cardiac disease, the most severe and main cause of disability and mortality in patients with Chagas disease [2] . The search for risk factors associated with the development of cardiomyopathy is critical because it could reduce the morbidity and mortality associated with Chagas disease by allowing for the administration of early treatment.
It is currently accepted that the host's immune response is essential in determining the course of infection. Cytotoxic cells and inflammatory cytokines, such as interferon (IFN)-␥ and tumor necrosis factor (TNF)-␣, while essential for protection during the acute phase of the disease, have been correlated with tissue damage and the severity of chronic disease [3] [4] [5] . Thus, controlling the inflammatory response seems to be important to avoid establishment of pathology. We have shown that high expression of interleukin (IL)-10 by monocytes was observed in patients with the indeterminate form, but not in patients with cardiac disease, suggesting a lack of immunological control in patients with the cardiac clinical form [5] .
IL-10 is capable of down-modulating the immune response by indirect or direct affects on T cells. The IL-10 gene promoter region is highly polymorphic, and a correlation between the polymorphic allele A of the Ϫ1082G/A polymorphism with low IL-10 production has been described [6] . Recently, a correlation between BAT, a putative anti-inflammatory molecule gene polymorphism, and chagasic cardiomyopathy was observed [7] .
We hypothesize that low IL-10 expression is associated with the development of cardiomyopathy in chronic chagasic patients. Thus, this study was designed to investigate whether the functional IL-10 gene polymorphism Ϫ1082G/A is a predisposing factor for the development of cardiomyopathy in individuals infected with T. cruzi and whether IL-10 expression can be correlated with cardiac function. The identification of genetic markers related to susceptibility and/or resistance is critical for identifying patients with greater potential to progress toward severe forms of disease and, therefore, to enable possible interventions to prevent disease development or improve treatment choices.
Materials and methods. This study employed a crosssectional design that involved patients from Chagas-endemic areas in Minas Gerais, Brazil (under the medical care of M.O.C.R.). One hundred fifty-five patient volunteers with specific serological results positive for T. cruzi who were in the chronic phase of the disease were enrolled in this study. Detailed evaluations, including physical examinations, an electrocardiogram, chest radiographs, and an echocardiogram were performed to classify patients into different clinical groups, as we have described else-where [2] . These clinical groups were as follows: indeterminate patients (Ind; n ϭ 58), who were asymptomatic and presented no cardiac alterations; nondilated cardiac patients (C; n ϭ 44), who presented cardiac alterations such as right and/or left branch blockage and different degrees of conductive functional alterations but no heart dilation; and dilated cardiac patients (DC; n ϭ 53), who presented severe cardiomyopathy with heart enlargement. We also included in our analysis individuals without Chagas disease (N; n ϭ 43), as determined by specific negative serological test results. The exclusion criteria were as follows: presence of diabetes mellitus, thyroid dysfunction, renal insufficiency, chronic obstructive pulmonary disease, and/or rheumatic or autoimmune diseases. The demographic characteristics of the clinical groups as well as the genotype and allele frequency of the IL-10 Ϫ1082G/A polymorphism are summarized in table 1.
After clinical characterization, a sample of 10 individuals was selected for evaluation of the association between IL-10 expression and heart function. These chagasic patients presented with the indeterminate (n ϭ 6) or cardiac (n ϭ 4) clinical forms, and left-ventricular ejection fraction (LVEF) was used as a systolic dysfunction parameter. Informed written consent was obtained from all individuals, and the study was approved by the ethical committee of Universidade Federal de Minas Gerais (COEP-UFMG-ETIC006/05).
Cells from 198 individuals were obtained by use of an oral swab procedure performed with a sterile plastic spatula. DNA extraction was performed by the silica method, as we described previously [8] . The IL-10 Ϫ1082G/A polymorphism was assessed by PCR amplification, followed by digestion with restriction enzyme. PCR primers sequences were 5'CCAAGA-CAACACTACTAAGGCTCCTTT3' and 5'GCTTCTTATATG-CTAGTCAGGTA3', with an expected PCR product size of 377 bp, as described elsewhere [9] . Products were digested with 5 units of restriction enzyme EcoNI (New England Biolabs) at 37°C for 4 h. Digestion products of 280 ϩ 97 bp and 253 ϩ 97 ϩ 27 bp were obtained for A and G alleles, visualized by silver-stained 10% acrylamide gel.
Approximately 20 mL of blood was collected from each of the 10 chagasic patients to evaluate expression levels of IL-10 by peripheral blood mononuclear cells (PBMCs) after in vitro stimulation with parasite antigens. PBMCs from chagasic patients were obtained by Ficoll-Hypaque gradient (Amersham Biosciences), as we described elsewhere [10] . Cultures used 2 ϫ 10 5 cells/well in a 96-well plate in the presence or absence of T. cruzi trypomastigote-soluble antigen (TRP; 20g/mL final concen- c Individuals with the G allele express higher levels of interleukin (IL)-10 than those with the A allele. Ind ϫ DC ϫ C : 2 ϭ 10.25; P ϭ .006; Ind ϫ C: P ϭ .001; OR, 0.84 (95% CI, 1.44 -4.95).
tration) [5] and were incubated for approximately 18 h at 37°C (5% CO 2 ). Brefeldin A (10 g/mL; Sigma) was added during the last 4 h of culture, and intracellular staining for IL-10 that used phycoerythrin (PE)-labeled anti-IL-10 monoclonal antibodies (Caltag) was performed as we described elsewhere [5, 10] . A total of 30,000 events/sample were acquired using a FACScan (Becton-Dickinson). IL-10 expression was analyzed by gating on monocytes and lymphocytes, and the mean intensity of expression was obtained for IL-10 ϩ cells. Unlabeled cells and PElabeled isotype controls were present in all experiments.
Statistical analysis of data was performed by using JMP statistical software (version 5.0.1; SAS Institute). The 2 test was used to compare genotype and allele frequencies between clinical groups. Odds ratios (OR) with 95% confidence intervals (CIs) were calculated for a 2 ϫ 2 contingency table. The clinical groups obeyed Hardy-Weinberg equilibrium when the expected and observed genotype frequencies were compared. Correlation analysis for IL-10 expression and LVEF was performed using linear regression and Spearman's rank correlation test. P Ͻ .05 was considered statistically significant.
Results. Table 1 shows age, sex, and clinical group, as well as genotype and allele distribution for all individuals analyzed in this study. An association between the occurrence of dilated cardiomyopathy and male sex was observed (comparison of C ϫ DC: 2 ϭ 5.6; P ϭ .018; OR, 0.158; [95% CI, 0.16 -0.85]). IL-10 polymorphism analysis showed that genotype distribution was nonrandom among the 3 clinical groups evaluated in this study ( 2 ϭ 12.38; P ϭ .015) (table 1). Comparison of genotype distribution between patients in the Ind group and patients with each of the other 2 symptomatic forms (the DC and C groups) showed association between C ϫ Ind ( 2 ϭ 12.35; P Ͻ .01). The frequency of the polymorphic allele A (associated with lower expression of IL-10) was higher in the C group than in the Ind group (P Ͻ .01; OR, 0.84 [95% CI, 1.44 -4.95]) (table 1). Because differences in IL-10 levels were associated with homozygous and heterozygous genotypes [11] , we also analyzed our data by grouping the patients as G ϩ (GG or GA genotypes, with higher expression of IL-10) and G Ϫ (AA, with lower expression of IL-10). These analyses showed an association between the occurrence of the G Ϫ genotype and the C group, when compared with the Ind group (P Ͻ .01; OR, 1.6 [95% CI, 1.63-8.71]). Comparisons between the Ind and DC groups or the C and DC groups did not show association with any genotype or allele frequency.
Given the observed association between IL-10 polymorphism and the cardiac form of Chagas disease, we assessed the mean fluorescence intensity of IL-10 produced by TRP-stimulated PBMCs. We then evaluated the correlation between IL-10 intensity and the LVEF as an assessment of cardiac function, as described above. We observed a correlation between low levels of IL-10 expression and low LVEF values (figure 1). Conversely, higher levels of IL-10 were correlated with high LVEF values, which were related to better prognosis for Chagas disease.
Discussion. Chronic myocarditis is the main cause of disability and death in human Chagas disease, with prognosis determined by ascertaining the severity of heart lesions, which are correlated with the myocardial inflammatory process [1, 2] . The goal of this study was to evaluate the influence of host genetic factors, specifically of the Ϫ1082G/A IL-10 polymorphism, on the development of chagasic cardiomyopathy. Our results demonstrated an association between the low-expressing A allele of the IL-10 gene and the cardiac form of Chagas disease. Additionally, we showed that the lower the expression of IL-10, the worse the heart function of chagasic patients, as measured by LVEF. Moreover, an association between male sex and dilated instead of nondilated cardiomyopathy was observed (table 1) . A Brazilian study that evaluated prognostic factors for mortality in human Chagas disease also showed male sex as a risk factor for worse disease outcome [12] .
The IL-10 Ϫ1082G/A polymorphism has also been associated with the outcome of autoimmune and/or inflammatory diseases [9, 11] . Our data showed that genotypic and allelic frequencies for this locus are in accordance with those observed in another study performed previously among the Brazilian population [13] . However, the G allele, as well as the GG genotype, were more frequent in white populations [9] than in Brazilians. In the present study, we did not group Brazilians into ethnic groups on the basis of skin colors and other phenotypic characteristics because another study [14] clearly demonstrated that in highly miscegenated populations, such as Brazilians, this type of stratification does not correlate with genotype.
Comparison between uninfected individuals and chagasic patients with respect to the genotype and allele frequency for the IL-10 polymorphism did not show any differences. However, since the uninfected individuals were never exposed to the parasite, the best measure of the polymorphisms' association with Chagas disease pathology is the comparison between asymptomatic individuals (the Ind group) and those who developed cardiac disease after T. cruzi infection. The single-nucleotide polymorphism at the Ϫ1082 promoter region of the IL-10 gene follows a nonrandom distribution among Chagas disease patients. A difference was found between the C and Ind groups with respect to the occurrence of the G Ϫ genotype and the A allele, putative low producers of IL-10 (table 1) . No difference was found between the DC and Ind groups. On the basis of this evidence, we suggest that the pathogenesis of the nondilated and dilated cardiac forms may involve distinct mechanisms, although additional studies should be undertaken to test this hypothesis. Others have also shown associations between gene polymorphisms and susceptibility to cardiomyopathy in Chagas disease [7, 15, 16] . These findings suggest that the human genetic background is a critical factor that could influence susceptibility and the outcome of cardiomyopathy in human Chagas disease.
Phenotypic IL-10 expression levels were correlated with LVEF values, a clinical criterion that measures heart function. Patients selected for this analysis displayed a G ϩ genotype for IL-10, with a potential for high production of this cytokine. We showed that the higher the expression of IL-10, the better the heart function as evaluated by LVEF levels, suggesting a protective role for IL-10 in Chagas disease pathology. In conclusion, IL-10 is associated with cardiac function, and the IL-10 gene polymorphism predisposes individuals infected with T. cruzi to cardiac disease.
